BofA Securities Downgrades Ascendis Pharma (ASND) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CRWV
2. CSCO
3. SMCI
4. GAMI
5. LITE
6. SPY
7. ONON
8. CAVA
9. USO
10. NVDA

October 20, 2021 6:06 AM EDT
Get Alerts ASND Hot Sheet
Price: $255.46 --0%

Rating Summary:
    21 Buy, 1 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 9 | New: 6
Join SI Premium – FREE

BofA Securities analyst Tazeen Ahmad downgraded Ascendis Pharma (NASDAQ: ASND) from Buy to Neutral with a price target of $169.00 (from $164.00).


For an analyst ratings summary and ratings history on Ascendis Pharma click here. For more ratings news on Ascendis Pharma click here.


Shares of Ascendis Pharma closed at $153.49 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades